CLINICAL_TRIALS
research
· 2025-06-10
Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]
Summary
This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves survival in common no…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College, London | Conditions: Cancer, Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING